-transparent.png){kind=logo}
Many arteries of the head upon electrical stimulation of the non-adrenergic nerve terminals present in their wall exhibit dilation that is only partially reduced by atropine. The results of three types of experiments are presented that tend to implicate vasoactive intestinal polypeptide (VIP) a known vasodilator, as an atropine-resistant dilator transmitter. VIP activity is high in vessels that exhibit neurogenic dilation and low in those that do not. It is released from two arteries that show such dilation upon neurogenic field stimulation and VIP antiserum reduces neurogenic dilation. It is proposed that VIP as well as acetylcholine are released from the innervation of some cranial arteries and together in a number of animals of least are responsible for part of the complex neurogenic dilation witnessed in these vessels. Although substance P is present in nerves found within the wall of cerebral and other cranial blood vessels, it is either ineffective as a dilator in vessels that show a sizeable dilation to electrical stimulation, or else exhibits marked, rapid, persistent tachyphylaxis.
J A Bevan, and
M Moscowitz, and
S I Said, and
G Buga
January 1986,
Stroke,
J A Bevan, and
M Moscowitz, and
S I Said, and
G Buga
December 1989,
Cell biology international reports,
J A Bevan, and
M Moscowitz, and
S I Said, and
G Buga
May 1984,
Science (New York, N.Y.),
J A Bevan, and
M Moscowitz, and
S I Said, and
G Buga
March 1986,
The Journal of urology,
J A Bevan, and
M Moscowitz, and
S I Said, and
G Buga
August 1987,
Life sciences,
J A Bevan, and
M Moscowitz, and
S I Said, and
G Buga
January 1991,
Proceedings of the Western Pharmacology Society,
J A Bevan, and
M Moscowitz, and
S I Said, and
G Buga
June 1986,
General and comparative endocrinology,
J A Bevan, and
M Moscowitz, and
S I Said, and
G Buga
August 1997,
Regulatory peptides,
J A Bevan, and
M Moscowitz, and
S I Said, and
G Buga
January 1984,
Peptides,
J A Bevan, and
M Moscowitz, and
S I Said, and
G Buga
July 1982,
Gastroenterology,
